Baird Maintains Neutral on Inspire Medical Systems, Raises Price Target to $59
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Baird analyst Mike Polark maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $54 to $59.
Baird analyst Mike Polark maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $54 to $59.